SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung4/22/2015 7:50:50 AM
   of 5581
 
FDA Considers Regulating Homeopathic Products

Tue, Apr 21, 2015 -- 9:00 AM

The Food and Drug Administration began hearings Monday on the regulation and marketing of homeopathic products. Homeopathy is based on the notion that illnesses can be cured by highly diluted doses of the substance causing the illness. At issue is whether or not these remedies should go through a drug approval process similar to conventional treatments. Considered a pseudo-science by the medical establishment, patients and practitioners swear by the efficacy of homeopathy. We'll get an update on the hearings and discuss whether or not the FDA should regulate homeopathic products.

Host: Michael Krasny



Guests:
  • Cynthia Schnedar, director of the Office of Compliance at the Center for Drug Evaluation and Research
  • Karen Allen, board member of the Integrative Health Policy Consortium
  • Adriane Fugh-Berman, associate professor of pharmacology at Georgetown University
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext